University of Nebraska

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

186

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

9 drugs in development

Phase 32

Phase 26

Phase 12

By Therapeutic Area

top 6

Oncology

542%

Nephrology

18%

Immunology

18%

Respiratory

18%

Infectious Disease

18%

Psychiatry

18%

R&D Momentum

66/100

Pipeline Velocity

32/100

Trial Completion Rate

62/100

Pipeline Concentration

22/100

Pipeline Freshness

49/100

Strategic Signals

↗Active in Nephrology but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Jul 10, 2026

Recruiting

Safety and Efficacy of Cannabidiol (CBD) for Symptoms of Post-Traumatic Stress Disorder (PTSD) in Adults Using Liquid StructureTM Formulation (NantheiaTM ATL5).

Jul 10, 2026

Recruiting

Early Rheumatoid Arthritis Lung Disease Study

Jul 2, 2026

Recruiting

Halt Aging in Survivors of Blood Cancers: the HALTAging-1 Study

Earlier

Jun 30, 2026TrialWhole Versus Partial Gland Boost During Prostate SBRT (Gland Boost)

Jun 30, 2026TrialIntegrated Cancer Repository for Cancer Research

Jun 27, 2026TrialA Phase II Study of Neoadjuvant Chemotherapy With and Without Trastuzumab in Patients With Breast Cancer

Jun 26, 2026TrialEvaluating the Safety and Efficacy of Coenzyme Q10 and Vitamin E Dual Therapy in Mitigating Chronic Off-Target Radiation Toxicity

Jun 25, 2026TrialImpact of Nrf2 Activation on Macrovascular Function, Microvascular Function, Leg Function, and Walking Capacity in Patients With Peripheral Artery Disease

4 more events

Mar 1, 2026TrialIsotretinoin vs hCG for Male Infertility Due to Low or Absent Sperm

Mar 1, 2026TrialButyric Acid Supplementation for Gut Improvement After Cardiac Surgery in Kids

Feb 1, 2026TrialAbiraterone/Prednisone + Standard ADT vs Standard ADT for Prostate Cancer Patients With PSMA-Positive Conventional Imaging Negative Pelvic Lymphadenopathy

Jan 5, 2026TrialIntranasal Oxytocin Intervention for Caregivers to Persons With Dementia

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Therapeutic Area

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Cardiovascular(1 drug)

—

Cardiovascular(1 drug)

Immunology(1 drug)

—

Immunology(1 drug)

Infectious Disease(1 drug)

—

Infectious Disease(1 drug)

Nephrology(1 drug)

—

Nephrology(1 drug)

Oncology(5 drugs)

—

Oncology(5 drugs)

Psychiatry(1 drug)

—

Psychiatry(1 drug)

Respiratory(1 drug)

—

Respiratory(1 drug)

Unknown / Other(1 drug)

—

Unknown / Other(1 drug)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)